Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

ClinicalTrials.gov ID: NCT03077438

Public ClinicalTrials.gov record NCT03077438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age

Study identification

NCT ID
NCT03077438
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
1,000 participants

Conditions and interventions

Interventions

  • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Biological
  • Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Biological

Biological

Eligibility (public fields only)

Age range
2 Years to 9 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2017
Primary completion
Oct 9, 2017
Completion
Oct 9, 2017
Last update posted
Mar 27, 2022

2017

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
34
Facility City State ZIP Site status
Investigational Site Birmingham Alabama 35205
Investigational Site Dothan Alabama 36305
Investigational Site Tucson Arizona 85741
Investigational Site Jonesboro Arkansas 72401
Investigational Site Anaheim California 92804
Investigational Site Downey California 90241
Investigational Site Paramount California 90723
Investigational Site San Diego California 92103
Investigational Site Council Bluffs Iowa 51503
Investigational Site Bardstown Kentucky 40004
Investigational Site Nicholasville Kentucky 40356
Investigational Site Metairie Louisiana 70006
Investigational Site Woburn Massachusetts 01801
Investigational Site Bridgeton Missouri 63044
Investigational Site Kansas City Missouri 64114
Investigational Site Omaha Nebraska 68134
Investigational Site Cincinnati Ohio 45245
Investigational Site Cleveland Ohio 44121
Investigational Site Dayton Ohio 45414
Investigational Site Fairfield Ohio 45014
Investigational Site Grants Pass Oregon 97527
Investigational Site Gresham Oregon 92103
Investigational Site Erie Pennsylvania 16506
Investigational Site Hermitage Pennsylvania 16148
Investigational Site Goodlettsville Tennessee 37072
Investigational Site Tullahoma Tennessee 37388
Investigational Site Layton Utah 84041
Investigational Site Orem Utah 84057
Investigational Site Roy Utah 84067
Investigational Site Salt Lake City Utah 84109
Investigational Site Salt Lake City Utah 84121
Investigational Site South Jordan Utah 84095
Investigational Site Syracuse Utah 84075
Investigational Site West Jordan Utah 848088
Investigational Site Midlothian Virginia 23113

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03077438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03077438 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →